Researchers at King’s College London have developed a powerful new AI model that can predict a person’s risk of ...

Eli Lilly has launched Mounjaro (Tirzepatide) in India, being the first top pharma major to bring out a GLP-1/GIP dual-action weight-loss and diabetes drug into the country.

Americans living in rural communities throughout the country could see their access to health care diminish if Congress ...

Thousands of Oregonians may lose in-network access to OHSU doctors if UnitedHealthcare and the hospital can't agree on a new ...

An experimental Alzheimer's treatment from Boston researchers may be able to treat both dementia and depression symptoms.

Copycat versions of Eli Lilly’s diabetes drug Mounjaro and obesity drug Zepbound were supposed to go away this week. They’re ...

As Dr. Mallika Marshall reports, dementia and depression often go hand-in-hand in patients with Alzheimer's disease. Now, an experimental home-based electrical therapy may be able help.

In 2023, the United States marked a major milestone in the battle against a longstanding public health crisis: adult obesity rates dropped for the first time in a decade. Researchers pointed to GLP-1s ...

Shares of Allurion Technologies on Friday surged a day after the company said it received positive results about the effectiveness of its gastric balloon in combination with a low dose of the ...

Weight trajectories differed significantly among patients with HIV during the first year of ART, with no associations observed between weight gain and type of ART regimen.

Despite weight loss and glycemic control, experts caution that type 2 diabetes remission is not a cure and that pancreatic ...

Engage in strength training a minimum of three times weekly. This can be any form of exercise that challenges your muscles. The exercises should be becoming increasingly difficult (or the weights ...